BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Dresner SM, Wayman J, Shenfine J, Harris A, Hayes N, Griffin SM. Pattern of recurrence following subtotal oesophagectomy with two field lymphadenectomy. Br J Surg. 2000;87:362-373. [PMID: 10718968 DOI: 10.1046/j.1365-2168.2000.01541.x] [Cited by in Crossref: 154] [Cited by in F6Publishing: 138] [Article Influence: 7.7] [Reference Citation Analysis]
Number Citing Articles
1 Lagarde SM, de Boer JD, ten Kate FJW, Busch ORC, Obertop H, van Lanschot JJB. Postoperative Complications After Esophagectomy for Adenocarcinoma of the Esophagus Are Related to Timing of Death Due to Recurrence. Annals of Surgery 2008;247:71-6. [DOI: 10.1097/sla.0b013e31815b695e] [Cited by in Crossref: 101] [Cited by in F6Publishing: 31] [Article Influence: 7.2] [Reference Citation Analysis]
2 Gwynne S, Hurt C, Evans M, Holden C, Vout L, Crosby T. Definitive chemoradiation for oesophageal cancer--a standard of care in patients with non-metastatic oesophageal cancer. Clin Oncol (R Coll Radiol). 2011;23:182-188. [PMID: 21232928 DOI: 10.1016/j.clon.2010.12.001] [Cited by in Crossref: 72] [Cited by in F6Publishing: 67] [Article Influence: 6.5] [Reference Citation Analysis]
3 Kim TJ, Lee KH, Kim YH, Sung SW, Jheon S, Cho S, Lee KW. Postoperative Imaging of Esophageal Cancer: What Chest Radiologists Need to Know. RadioGraphics 2007;27:409-29. [DOI: 10.1148/rg.272065034] [Cited by in Crossref: 25] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
4 Di Franco F, Lamb PJ, Karat D, Hayes N, Griffin SM. Iatrogenic perforation of localized oesophageal cancer. British Journal of Surgery 2008;95:837-9. [DOI: 10.1002/bjs.6055] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
5 Crosby T, Evans M. The Management of Locally Advanced Carcinoma of the Oesophagus — SCOPE for Improvement? Clinical Oncology 2009;21:281-4. [DOI: 10.1016/j.clon.2009.01.007] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
6 Kato H, Fukuchi M, Miyazaki T, Nakajima M, Kimura H, Faried A, Sohda M, Fukai Y, Masuda N, Manda R, Ojima H, Tsukada K, Oriuchi N, Endo K, Kuwano H. Positron emission tomography in esophageal cancer. Esophagus 2005;2:111-21. [DOI: 10.1007/s10388-005-0053-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
7 Kofoed SC, Calatayud D, Jensen LS, Helgstrand F, Achiam MP, De Heer P, Svendsen LB; Danish Esophageal, Cardia and Stomach Cancer Group. Intrathoracic anastomotic leakage after gastroesophageal cancer resection is associated with increased risk of recurrence. J Thorac Cardiovasc Surg. 2015;150:42-48. [PMID: 25986493 DOI: 10.1016/j.jtcvs.2015.04.030] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 3.4] [Reference Citation Analysis]
8 Shim YM, Yun J, Im YH, Lee G, Kang D, Cho J, Kim K, Park SI, Na KJ, Kim SB, Zo JI. The efficacy of adjuvant chemotherapy with capecitabine and cisplatin after surgery in locally advanced esophageal squamous cell carcinoma: a multicenter randomized phase III trial. Dis Esophagus 2021:doab040. [PMID: 34155501 DOI: 10.1093/dote/doab040] [Reference Citation Analysis]
9 Davies AR, Deans DAC, Penman I, Plevris JN, Fletcher J, Wall L, Phillips H, Gilmour H, Patel D, De Beaux A, Paterson-brown S. The multidisciplinary team meeting improves staging accuracy and treatment selection for gastro-esophageal cancer. Diseases of the Esophagus 2006;19:496-503. [DOI: 10.1111/j.1442-2050.2006.00629.x] [Cited by in Crossref: 99] [Cited by in F6Publishing: 92] [Article Influence: 6.2] [Reference Citation Analysis]
10 Zhong D, Zhou Y, Li Y, Wang Y, Zhou W, Cheng Q, Chen L, Zhao J, Li X, Yan X. Intraoperative recurrent laryngeal nerve monitoring: a useful method for patients with esophageal cancer: RLNM for esophageal cancer. Dis Esophagus 2014;27:444-51. [DOI: 10.1111/j.1442-2050.2012.01414.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 1.7] [Reference Citation Analysis]
11 Song Y, Wang Z, Liu X, Jiang W, Shi M. CCR7 and VEGF-C: molecular indicator of lymphatic metastatic recurrence in pN0 esophageal squamous cell carcinoma after Ivor-Lewis esophagectomy? Ann Surg Oncol 2012;19:3606-12. [PMID: 22644515 DOI: 10.1245/s10434-012-2419-y] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 1.9] [Reference Citation Analysis]
12 Procopio F, Marano S, Gentile D, Da Roit A, Basato S, Riva P, De Vita F, Torzilli G, Castoro C. Management of Liver Oligometastatic Esophageal Cancer: Overview and Critical Analysis of the Different Loco-Regional Treatments. Cancers (Basel) 2019;12:E20. [PMID: 31861604 DOI: 10.3390/cancers12010020] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
13 Port JL, Nasar A, Lee PC, Paul S, Stiles BM, Andrews W, Altorki NK. Definitive Therapy for Isolated Esophageal Metastases Prolongs Survival. The Annals of Thoracic Surgery 2012;94:413-20. [DOI: 10.1016/j.athoracsur.2012.03.075] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
14 Liu CJ, Cheng JC, Lee JM, Cheng MF, Tzen KY, Yen RF. Patterns of nodal metastases on 18F-FDG PET/CT in patients with esophageal squamous cell carcinoma are useful to guide treatment planning of radiotherapy. Clin Nucl Med 2015;40:384-9. [PMID: 25674870 DOI: 10.1097/RLU.0000000000000714] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
15 Chen G, Wang Z, Liu XY, Liu FY. Recurrence pattern of squamous cell carcinoma in the middle thoracic esophagus after modified Ivor-Lewis esophagectomy. World J Surg. 2007;31:1107-1114. [PMID: 17426905 DOI: 10.1007/s00268-006-0551-1] [Cited by in Crossref: 45] [Cited by in F6Publishing: 64] [Article Influence: 3.0] [Reference Citation Analysis]
16 Deng W, Yang Z, Dong X, Yu R, Wang W. Conditional survival in patients with esophageal or gastroesophageal junction cancer after receiving various treatment modalities. Cancer Med 2021;10:659-74. [PMID: 33314798 DOI: 10.1002/cam4.3651] [Reference Citation Analysis]
17 Yoshioka S, Fujiwara Y, Sugita Y, Okada Y, Yano M, Tamura S, Yasuda T, Takiguchi S, Shiozaki H, Monden M. Real-time rapid reverse transcriptase-polymerase chain reaction for intraoperative diagnosis of lymph node micrometastasis: clinical application for cervical lymph node dissection in esophageal cancers. Surgery. 2002;132:34-40. [PMID: 12110793 DOI: 10.1067/msy.2002.125306] [Cited by in Crossref: 43] [Cited by in F6Publishing: 41] [Article Influence: 2.2] [Reference Citation Analysis]
18 Betancourt Cuellar SL, Palacio DP, Wu CC, Carter BW, Correa AM, Hofstetter WL, Marom EM. 18FDG-PET/CT is useful in the follow-up of surgically treated patients with oesophageal adenocarcinoma. Br J Radiol 2018;91:20170341. [PMID: 29125331 DOI: 10.1259/bjr.20170341] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
19 Guo J, Yu X, Gu J, Lin Z, Zhao G, Xu F, Lu C, Ge D. Regulation of CXCR4/AKT-signaling-induced cell invasion and tumor metastasis by RhoA, Rac-1, and Cdc42 in human esophageal cancer. Tumour Biol 2016;37:6371-8. [PMID: 26631033 DOI: 10.1007/s13277-015-4504-x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 3.6] [Reference Citation Analysis]
20 Tanaka K, Yamasaki M, Makino T, Yamashita K, Saitoh T, Takahashi T, Kurokawa Y, Nakajima K, Motoori M, Kimura Y, Mano M, Mori M, Eguchi H, Doki Y. Analysis of prognostic factors in patients with lymph node recurrence after radical esophagectomy: importance of locoregional therapy. Esophagus 2021;18:195-202. [PMID: 32875459 DOI: 10.1007/s10388-020-00778-x] [Reference Citation Analysis]
21 Sugiyama M, Morita M, Yoshida R, Ando K, Egashira A, Takefumi O, Saeki H, Oki E, Kakeji Y, Sakaguchi Y, Maehara Y. Patterns and time of recurrence after complete resection of esophageal cancer. Surg Today. 2012;42:752-758. [PMID: 22370963 DOI: 10.1007/s00595-012-0133-9] [Cited by in Crossref: 36] [Cited by in F6Publishing: 30] [Article Influence: 3.6] [Reference Citation Analysis]
22 Doki Y, Ishikawa O, Kabuto T, Hiratsuka M, Sasaki Y, Ohigashi H, Kameyama M, Murata K, Yamada T, Miyashiro I, Yokoyama S, Imaoka S. Possible indication for surgical treatment of squamous cell carcinomas of the esophagus that involve the stomach. Surgery 2003;133:479-85. [PMID: 12773975 DOI: 10.1067/msy.2003.134] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
23 Hirose K, Saeki H, Nakashima Y, Kamori T, Fujimoto Y, Kawazoe T, Matsuoka H, Haruta Y, Sasaki S, Jogo T, Hu Q, Tsuda Y, Ando K, Oki E, Hiratsuka R, Oda Y, Mori M. Successful multidisciplinary treatment including repeated metastasectomy for recurrent squamous cell esophageal carcinoma: a case report. Surg Case Rep 2019;5:72. [PMID: 31053962 DOI: 10.1186/s40792-019-0634-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
24 Hsu PK, Wang BY, Huang CS, Wu YC, Hsu WH. Prognostic factors for post-recurrence survival in esophageal squamous cell carcinoma patients with recurrence after resection. J Gastrointest Surg. 2011;15:558-565. [PMID: 21327531 DOI: 10.1007/s11605-011-1458-1] [Cited by in Crossref: 58] [Cited by in F6Publishing: 54] [Article Influence: 5.3] [Reference Citation Analysis]
25 Chen J, Yin W, Yao H, Gu W. Salvage treatment for lymph node recurrence after radical resection of esophageal squamous cell carcinoma. Radiat Oncol 2019;14:169. [PMID: 31533757 DOI: 10.1186/s13014-019-1377-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
26 Chen H, Wang Z, Yang Z, Shang B, Liu X, Chen G. Prospective study of adjuvant radiotherapy on preventing lymph node metastasis after Ivor-lewis esophagectomy in esophageal cancer. Ann Surg Oncol 2013;20:2721-6. [PMID: 23463093 DOI: 10.1245/s10434-013-2928-3] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.7] [Reference Citation Analysis]
27 Rutegård M, Lagergren P. No influence of surgical volume on patients' health-related quality of life after esophageal cancer resection. Ann Surg Oncol 2008;15:2380-7. [PMID: 18523828 DOI: 10.1245/s10434-008-9964-4] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
28 Kaisaki S, Kitayama J, Ishigami H, Nagawa H. Solitary Nodal Recurrence in the Dorsal Area of the Thoracic Aorta After a Curative Resection of Esophageal Cancer: Report of Two Cases. Surg Today 2007;37:243-7. [DOI: 10.1007/s00595-006-3349-8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
29 Shimada H, Kitabayashi H, Nabeya Y, Okazumi S, Matsubara H, Funami Y, Miyazawa Y, Shiratori T, Uno T, Itoh H, Ochiai T. Treatment response and prognosis of patients after recurrence of esophageal cancer. Surgery 2003;133:24-31. [PMID: 12563234 DOI: 10.1067/msy.2003.31] [Cited by in Crossref: 94] [Cited by in F6Publishing: 82] [Article Influence: 4.9] [Reference Citation Analysis]
30 Jamieson GG, Lamb PJ, Thompson SK. The role of lymphadenectomy in esophageal cancer. Ann Surg. 2009;250:206-209. [PMID: 19638911 DOI: 10.1097/sla.0b013e3181b16cd1] [Cited by in Crossref: 48] [Cited by in F6Publishing: 18] [Article Influence: 3.7] [Reference Citation Analysis]
31 Manner H, Pech O, Heldmann Y, May A, Pauthner M, Lorenz D, Fisseler-Eckhoff A, Stolte M, Vieth M, Ell C. The frequency of lymph node metastasis in early-stage adenocarcinoma of the esophagus with incipient submucosal invasion (pT1b sm1) depending on histological risk patterns. Surg Endosc. 2015;29:1888-1896. [PMID: 25294553 DOI: 10.1007/s00464-014-3881-3] [Cited by in Crossref: 54] [Cited by in F6Publishing: 49] [Article Influence: 6.8] [Reference Citation Analysis]
32 Chen G, Wang Z, Liu XY, Liu FY. Adjuvant radiotherapy after modified Ivor-Lewis esophagectomy: can it prevent lymph node recurrence of the mid-thoracic esophageal carcinoma? Ann Thorac Surg. 2009;87:1697-1702. [PMID: 19463580 DOI: 10.1016/j.athoracsur.2009.03.060] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 1.7] [Reference Citation Analysis]
33 Manner H, Wetzka J, May A, Pauthner M, Pech O, Fisseler-Eckhoff A, Stolte M, Vieth M, Lorenz D, Ell C. Early-stage adenocarcinoma of the esophagus with mid to deep submucosal invasion (pT1b sm2-3): the frequency of lymph-node metastasis depends on macroscopic and histological risk patterns. Dis Esophagus. 2017;30:1-11. [PMID: 26952572 DOI: 10.1111/dote.12462] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
34 Kimoto T, Yamazaki H, Suzuki G, Aibe N, Masui K, Tatekawa K, Sasaki N, Fujiwara H, Shiozaki A, Konishi H, Nakamura S, Yamada K. Local field radiotherapy without elective nodal irradiation for postoperative loco-regional recurrence of esophageal cancer. Jpn J Clin Oncol 2017;47:809-14. [PMID: 28903531 DOI: 10.1093/jjco/hyx092] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
35 Mantziari S, Allemann P, Winiker M, Demartines N, Schäfer M. Locoregional Tumor Extension and Preoperative Smoking are Significant Risk Factors for Early Recurrence After Esophagectomy for Cancer. World J Surg 2018;42:2209-17. [DOI: 10.1007/s00268-017-4422-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
36 Yasuda T, Higuchi I, Yano M, Miyata H, Yamasaki M, Takiguchi S, Fujiwara Y, Hatazawa J, Doki Y. The impact of ¹⁸F-fluorodeoxyglucose positron emission tomography positive lymph nodes on postoperative recurrence and survival in resectable thoracic esophageal squamous cell carcinoma. Ann Surg Oncol 2012;19:652-60. [PMID: 21769466 DOI: 10.1245/s10434-011-1928-4] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 2.2] [Reference Citation Analysis]
37 Omari J, Heinze C, Wilck A, Hass P, Seidensticker M, Damm R, Fischbach K, Ricke J, Pech M, Powerski M. Image-guided interstitial high-dose-rate brachytherapy in the treatment of metastatic esophageal squamous cell carcinoma. J Contemp Brachytherapy 2018;10:439-45. [PMID: 30479621 DOI: 10.5114/jcb.2018.79230] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
38 Rehders A, Cupisti K, Schmitt M, Renter MA, Kröpil P, Iskender O, Knoefel WT. Laparotomy enables retrograde dilatation and stent placement for malignant esophago-respiratory fistula. World J Surg Oncol 2008;6:8. [PMID: 18221555 DOI: 10.1186/1477-7819-6-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
39 Griffin SM, Burt AD, Jennings NA. Lymph node metastasis in early esophageal adenocarcinoma. Ann Surg. 2011;254:731-776; discussion 731-776. [PMID: 21997815 DOI: 10.1097/sla.0b013e318236048b] [Cited by in Crossref: 46] [Cited by in F6Publishing: 17] [Article Influence: 4.6] [Reference Citation Analysis]
40 Schiesser M, Schneider PM. Surgical strategies for adenocarcinoma of the esophagogastric junction. Recent Results Cancer Res. 2010;182:93-106. [PMID: 20676874 DOI: 10.1007/978-3-540-70579-6_8] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
41 Wakelin SJ, Deans C, Crofts TJ, Allan PL, Plevris JN, Paterson-Brown S. A comparison of computerised tomography, laparoscopic ultrasound and endoscopic ultrasound in the preoperative staging of oesophago-gastric carcinoma. Eur J Radiol. 2002;41:161-167. [PMID: 11809546 DOI: 10.1016/s0720-048x(01)00418-1] [Cited by in Crossref: 99] [Cited by in F6Publishing: 31] [Article Influence: 5.0] [Reference Citation Analysis]
42 Tapia Rico G, Townsend AR, Klevansky M, Price TJ. Liver metastases resection for gastric and esophageal tumors: is there enough evidence to go down this path? Expert Rev Anticancer Ther. 2016;16:1219-1225. [PMID: 27744727 DOI: 10.1080/14737140.2016.1249858] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
43 Ma GW, Situ DR, Ma QL, Long H, Zhang LJ, Lin P, Rong TH. Three-field vs two-field lymph node dissection for esophageal cancer: A meta-analysis. World J Gastroenterol 2014; 20(47): 18022-18030 [PMID: 25548502 DOI: 10.3748/wjg.v20.i47.18022] [Cited by in CrossRef: 50] [Cited by in F6Publishing: 54] [Article Influence: 6.3] [Reference Citation Analysis]
44 Rutegård M, Lagergren P, Rouvelas I, Mason R, Lagergren J. Surgical complications and long-term survival after esophagectomy for cancer in a nationwide Swedish cohort study. Eur J Surg Oncol 2012;38:555-61. [PMID: 22483704 DOI: 10.1016/j.ejso.2012.02.177] [Cited by in Crossref: 68] [Cited by in F6Publishing: 64] [Article Influence: 6.8] [Reference Citation Analysis]
45 Miyata H, Yamasaki M, Takahashi T, Murakami K, Kurokawa Y, Nakajima K, Takiguchi S, Mori M, Doki Y. Relevance of [18F]fluorodeoxyglucose positron emission tomography-positive lymph nodes after neoadjuvant chemotherapy for squamous cell oesophageal cancer. British Journal of Surgery 2013;100:1490-7. [DOI: 10.1002/bjs.9253] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 2.1] [Reference Citation Analysis]
46 Prasad P, Navidi M, Immanuel A, Griffin Obe SM, Phillips AW. Impact of trainee involvement in esophagectomy on clinical outcomes: a narrative systematic review of the literature. Dis Esophagus 2019;32:1-8. [PMID: 31398254 DOI: 10.1093/dote/doz063] [Reference Citation Analysis]
47 van der Schaaf M, Rutegård M, Lagergren P. The influence of surgical factors on persisting symptoms 3 years after esophageal cancer surgery: a population-based study in Sweden. Ann Surg Oncol 2013;20:1639-45. [PMID: 23271489 DOI: 10.1245/s10434-012-2690-y] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
48 Whitfield GA, Jackson A, Moore C, Price P. Radical chemoradiotherapy for adenocarcinoma of the distal oesophagus and oesophagogastric junction: what planning margins should we use? BJR 2008;81:921-34. [DOI: 10.1259/bjr/23903754] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
49 Wayman J, Bennett MK, Raimes SA, Griffin SM. The pattern of recurrence of adenocarcinoma of the oesophago-gastric junction. Br J Cancer. 2002;86:1223-1229. [PMID: 11953876 DOI: 10.1038/sj.bjc.6600252] [Cited by in Crossref: 61] [Cited by in F6Publishing: 56] [Article Influence: 3.1] [Reference Citation Analysis]
50 Chen H, Wang Z, Wang S, Zhang Z, Shi S. Effect and mechanism of RUNX3 gene on biological characteristics of human esophageal squamous cell carcinoma (ESCC). Med Oncol 2015;32. [DOI: 10.1007/s12032-014-0357-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
51 Griffiths E, Brummell Z, Gorthi G, Pritchard S, Welch I. The prognostic value of circumferential resection margin involvement in oesophageal malignancy. European Journal of Surgical Oncology (EJSO) 2006;32:413-9. [DOI: 10.1016/j.ejso.2005.11.024] [Cited by in Crossref: 41] [Cited by in F6Publishing: 38] [Article Influence: 2.6] [Reference Citation Analysis]
52 van Lanschot JJB, González DG, Richel DJ. Surgery, radiotherapy, and chemotherapy for esophageal carcinoma: . Current Opinion in Gastroenterology 2001;17:400-5. [DOI: 10.1097/00001574-200107000-00017] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
53 Nagatani S, Shimada Y, Kondo M, Kaganoi J, Maeda M, Watanabe G, Imamura M. A Strategy for Determining Which Thoracic Esophageal Cancer Patients Should Undergo Cervical Lymph Node Dissection. The Annals of Thoracic Surgery 2005;80:1881-6. [DOI: 10.1016/j.athoracsur.2005.04.051] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
54 Anandavadivelan P, Martin L, Djärv T, Johar A, Lagergren P. Nutrition Impact Symptoms Are Prognostic of Quality of Life and Mortality after Surgery for Oesophageal Cancer. Cancers (Basel) 2018;10:E318. [PMID: 30205530 DOI: 10.3390/cancers10090318] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
55 Shi Y, Ge X, Gao Z, Liu S, Sun X, Luo J. Gross tumor volume is an independent prognostic factor in patients with postoperative locoregional recurrence of esophageal squamous cell carcinoma. Oncol Lett 2019;18:2388-93. [PMID: 31452733 DOI: 10.3892/ol.2019.10529] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
56 Ishihara R, Oyama T, Abe S, Takahashi H, Ono H, Fujisaki J, Kaise M, Goda K, Kawada K, Koike T, Takeuchi M, Matsuda R, Hirasawa D, Yamada M, Kodaira J, Tanaka M, Omae M, Matsui A, Kanesaka T, Takahashi A, Hirooka S, Saito M, Tsuji Y, Maeda Y, Yamashita H, Oda I, Tomita Y, Matsunaga T, Terai S, Ozawa S, Kawano T, Seto Y. Risk of metastasis in adenocarcinoma of the esophagus: a multicenter retrospective study in a Japanese population. J Gastroenterol. 2017;52:800-808. [PMID: 27757547 DOI: 10.1007/s00535-016-1275-0] [Cited by in Crossref: 36] [Cited by in F6Publishing: 29] [Article Influence: 6.0] [Reference Citation Analysis]
57 Ozawa Y, Kamei T, Nakano T, Taniyama Y, Miyagi S, Ohuchi N. Characteristics of Postoperative Recurrence in Lymph Node-Negative Superficial Esophageal Carcinoma. World J Surg. 2016;40:1663-1671. [PMID: 26908240 DOI: 10.1007/s00268-016-3454-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
58 Lee SJ, Lee KS, Yim YJ, Kim TS, Shim YM, Kim K. Recurrence of squamous cell carcinoma of the oesophagus after curative surgery: rates and patterns on imaging studies correlated with tumour location and pathological stage. Clin Radiol. 2005;60:547-554. [PMID: 15851041 DOI: 10.1016/j.crad.2004.09.002] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 0.8] [Reference Citation Analysis]
59 Schipper PH, Cassivi SD, Deschamps C, Rice DC, Nichols FC, Allen MS, Pairolero PC. Locally Recurrent Esophageal Carcinoma: When is Re-Resection Indicated? The Annals of Thoracic Surgery 2005;80:1001-6. [DOI: 10.1016/j.athoracsur.2005.03.099] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 1.3] [Reference Citation Analysis]
60 Nakamura T, Ota M, Narumiya K, Sato T, Ohki T, Yamamoto M, Mitsuhashi N. Multimodal treatment for lymph node recurrence of esophageal carcinoma after curative resection. Ann Surg Oncol 2008;15:2451-7. [PMID: 18592318 DOI: 10.1245/s10434-008-0016-x] [Cited by in Crossref: 49] [Cited by in F6Publishing: 47] [Article Influence: 3.5] [Reference Citation Analysis]
61 Djärv T, Lagergren P. Quality of life after esophagectomy for cancer. Expert Review of Gastroenterology & Hepatology 2014;6:115-22. [DOI: 10.1586/egh.11.91] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 3.4] [Reference Citation Analysis]
62 Natsugoe S, Okumura H, Matsumoto M, Uchikado Y, Setoyama T, Uenosono Y, Ishigami S, Owaki T, Aikou T. The role of salvage surgery for recurrence of esophageal squamous cell cancer. Eur J Surg Oncol. 2006;32:544-547. [PMID: 16567077 DOI: 10.1016/j.ejso.2006.02.014] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 1.6] [Reference Citation Analysis]
63 Deans DAC, Wigmore SJ, de Beaux AC, Paterson-brown S, Garden OJ, Fearon KCH. Clinical prognostic scoring system to aid decision-making in gastro-oesophageal cancer. British Journal of Surgery 2007;94:1501-8. [DOI: 10.1002/bjs.5849] [Cited by in Crossref: 45] [Cited by in F6Publishing: 36] [Article Influence: 3.0] [Reference Citation Analysis]
64 Huddy JR, Thomas RL, Worthington TR, Karanjia ND. Liver metastases from esophageal carcinoma: is there a role for surgical resection? Dis Esophagus. 2015;28:483-487. [PMID: 24898890 DOI: 10.1111/dote.12233] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 3.5] [Reference Citation Analysis]
65 Lagarde SM, ten Kate FJ, Richel DJ, Offerhaus GJ, van Lanschot JJ. Molecular prognostic factors in adenocarcinoma of the esophagus and gastroesophageal junction. Ann Surg Oncol. 2007;14:977-991. [PMID: 17122988 DOI: 10.1245/s10434-006-9262-y] [Cited by in Crossref: 46] [Cited by in F6Publishing: 40] [Article Influence: 2.9] [Reference Citation Analysis]
66 Mason R. Palliation of oesophageal cancer. Surgical Oncology 2001;10:123-6. [DOI: 10.1016/s0960-7404(01)00026-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
67 Hsu PK, Chen HS, Huang CS, Liu CC, Hsieh CC, Hsu HS, Wu YC, Wu SC. Patterns of recurrence after oesophagectomy and postoperative chemoradiotherapy versus surgery alone for oesophageal squamous cell carcinoma. Br J Surg 2017;104:90-7. [PMID: 27859017 DOI: 10.1002/bjs.10334] [Cited by in Crossref: 9] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
68 Shang QX, Chen LQ, Hu WP, Deng HY, Yuan Y, Cai J. Three-field lymph node dissection in treating the esophageal cancer. J Thorac Dis 2016;8:E1136-49. [PMID: 27867579 DOI: 10.21037/jtd.2016.10.20] [Cited by in Crossref: 9] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
69 Tan JT, Yang Y, Mao NQ, Liu DS, Huang DM, Pan H, Xie T, Pan Q, Yang L, Zhong JH, Zuo CT. Effect of neoadjuvant chemoradiotherapy on perioperative immune function of patients with locally advanced esophageal cancer. Dis Esophagus 2017;30:1-8. [PMID: 27766708 DOI: 10.1111/dote.12486] [Reference Citation Analysis]
70 Deng W, Yang J, Ni W, Li C, Chang X, Han W, Zhou Z, Chen D, Feng Q, Liang J, Lv J, Wang X, Wang X, Deng L, Wang W, Bi N, Zhang T, Li Y, Gao S, Xue Q, Mao Y, Sun K, Liu X, Fang D, Wang D, Li J, Zhao J, Shao K, Li Z, Chen X, Han L, Wang L, He J, Xiao Z. Postoperative Radiotherapy in Pathological T2-3N0M0 Thoracic Esophageal Squamous Cell Carcinoma: Interim Report of a Prospective, Phase III, Randomized Controlled Study. Oncologist 2020;25:e701-8. [PMID: 32083766 DOI: 10.1634/theoncologist.2019-0276] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
71 Ichida H, Imamura H, Yoshimoto J, Sugo H, Kajiyama Y, Tsurumaru M, Suzuki K, Ishizaki Y, Kawasaki S. Pattern of Postoperative Recurrence and Hepatic and/or Pulmonary Resection for Liver and/or Lung Metastases From Esophageal Carcinoma. World J Surg 2013;37:398-407. [DOI: 10.1007/s00268-012-1830-7] [Cited by in Crossref: 36] [Cited by in F6Publishing: 30] [Article Influence: 3.6] [Reference Citation Analysis]
72 Koterazawa Y, Oshikiri T, Takiguchi G, Hasegawa H, Yamamoto M, Kanaji S, Yamashita K, Matsuda T, Nakamura T, Fujino Y, Tominaga M, Suzuki S, Kakeji Y. Prophylactic Cervical Lymph Node Dissection in Thoracoscopic Esophagectomy for Esophageal Cancer Increases Postoperative Complications and Does Not Improve Survival. Ann Surg Oncol 2019;26:2899-904. [DOI: 10.1245/s10434-019-07499-1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
73 Parry K, Visser E, van Rossum PS, Mohammad NH, Ruurda JP, van Hillegersberg R. Prognosis and Treatment After Diagnosis of Recurrent Esophageal Carcinoma Following Esophagectomy with Curative Intent. Ann Surg Oncol. 2015;22 Suppl 3:S1292-S1300. [PMID: 26334295 DOI: 10.1245/s10434-015-4840-5] [Cited by in Crossref: 39] [Cited by in F6Publishing: 37] [Article Influence: 5.6] [Reference Citation Analysis]
74 Burmeister BH, Smithers BM, Gebski V, Fitzgerald L, Simes RJ, Devitt P, Ackland S, Gotley DC, Joseph D, Millar J, North J, Walpole ET, Denham JW;  Trans-Tasman Radiation Oncology Group;  Australasian Gastro-Intestinal Trials Group. Surgery alone vs chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomised controlled phase III trial. Lancet Oncol. 2005;6:659-668. [PMID: 16129366 DOI: 10.1016/s1470-2045(05)70288-6] [Cited by in Crossref: 660] [Cited by in F6Publishing: 235] [Article Influence: 38.8] [Reference Citation Analysis]
75 Yasuda T, Yano M, Miyata H, Yamasaki M, Takiguchi S, Fujiwara Y, Doki Y. Prognostic Significance of (18)F-fluorodeoxyglucose Positron Emission Tomography (FDG-PET)-Positive Lymph Nodes Following Neoadjuvant Chemotherapy and Surgery for Resectable Thoracic Esophageal Squamous Cell Carcinoma. Ann Surg Oncol 2015;22:2599-607. [PMID: 25524011 DOI: 10.1245/s10434-014-4299-9] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
76 Miyata H, Yamasaki M, Kurokawa Y, Takiguchi S, Nakajima K, Fujiwara Y, Konishi K, Mori M, Doki Y. Survival factors in patients with recurrence after curative resection of esophageal squamous cell carcinomas. Ann Surg Oncol 2011;18:3353-61. [PMID: 21537861 DOI: 10.1245/s10434-011-1747-7] [Cited by in Crossref: 50] [Cited by in F6Publishing: 52] [Article Influence: 4.5] [Reference Citation Analysis]
77 Kunisaki C, Makino H, Takagawa R, Yamamoto N, Nagano Y, Fujii S, Kosaka T, Ono HA, Otsuka Y, Akiyama H, Ichikawa Y, Shimada H. Surgical outcomes in esophageal cancer patients with tumor recurrence after curative esophagectomy. J Gastrointest Surg 2008;12:802-10. [PMID: 17952515 DOI: 10.1007/s11605-007-0385-7] [Cited by in Crossref: 36] [Cited by in F6Publishing: 36] [Article Influence: 2.4] [Reference Citation Analysis]
78 Davies AR, Pillai A, Sinha P, Sandhu H, Adeniran A, Mattsson F, Choudhury A, Forshaw MJ, Gossage JA, Lagergren J, Allum WH, Mason RC. Factors associated with early recurrence and death after esophagectomy for cancer: Early Recurrence After Esophagectomy. J Surg Oncol 2014;109:459-64. [DOI: 10.1002/jso.23511] [Cited by in Crossref: 34] [Cited by in F6Publishing: 34] [Article Influence: 3.8] [Reference Citation Analysis]
79 Akhtar J, Wang Z, Jiang WP, Bi MM, Zhang ZP. Stathmin overexpression identifies high risk for lymphatic metastatic recurrence in pN0 esophageal squamous cell carcinoma patients. J Gastroenterol Hepatol 2014;29:944-50. [PMID: 24372619 DOI: 10.1111/jgh.12498] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
80 Yu E, Tai P, Younus J, Malthaner R, Truong P, Stitt L, Rodrigues G, Ash R, Dar R, Yaremko B, Tomiak A, Dingle B, Sanatani M, Vincent M, Kocha W, Fortin D, Inculet R. Postoperative extended-volume external-beam radiation therapy in high-risk esophageal cancer patients: a prospective experience. Curr Oncol 2009;16:48-54. [PMID: 19672424 DOI: 10.3747/co.v16i4.355] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
81 Hiyoshi Y, Morita M, Kawano H, Otsu H, Ando K, Ito S, Miyamoto Y, Sakamoto Y, Saeki H, Oki E, Ikeda T, Baba H, Maehara Y. Clinical significance of surgical resection for the recurrence of esophageal cancer after radical esophagectomy. Ann Surg Oncol. 2015;22:240-246. [PMID: 25124469 DOI: 10.1245/s10434-014-3970-5] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 2.5] [Reference Citation Analysis]
82 Mariette C, Balon JM, Piessen G, Fabre S, Van Seuningen I, Triboulet JP. Pattern of recurrence following complete resection of esophageal carcinoma and factors predictive of recurrent disease. Cancer. 2003;97:1616-1623. [PMID: 12655517 DOI: 10.1002/cncr.11228] [Cited by in Crossref: 258] [Cited by in F6Publishing: 243] [Article Influence: 13.6] [Reference Citation Analysis]
83 Nakagawa S, Kanda T, Kosugi S, Ohashi M, Suzuki T, Hatakeyama K. Recurrence pattern of squamous cell carcinoma of the thoracic esophagus after extended radical esophagectomy with three-field lymphadenectomy. J Am Coll Surg. 2004;198:205-211. [PMID: 14759776 DOI: 10.1016/j.jamcollsurg.2003.10.005] [Cited by in Crossref: 209] [Cited by in F6Publishing: 220] [Article Influence: 11.6] [Reference Citation Analysis]
84 Shimizu H, Shiozaki A, Fujiwara H, Komatsu S, Ichikawa D, Okamoto K, Murayama Y, Kuriu Y, Ikoma H, Nakanishi M, Ochiai T, Kokuba Y, Otsuji E. Predictive factors for early recurrence in patients with esophageal squamous cell carcinoma after curative esophagectomy. Esophagus 2012;9:17-24. [DOI: 10.1007/s10388-011-0308-2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
85 Toh Y, Oki E, Minami K, Okamura T. Follow-up and recurrence after a curative esophagectomy for patients with esophageal cancer: the first indicators for recurrence and their prognostic values. Esophagus 2010;7:37-43. [DOI: 10.1007/s10388-009-0221-0] [Cited by in Crossref: 23] [Cited by in F6Publishing: 10] [Article Influence: 1.9] [Reference Citation Analysis]
86 Tachibana M, Kinugasa S, Yoshimura H, Shibakita M, Tonomoto Y, Dhar DK, Tabara H, Nagasue N. En-bloc esophagectomy for esophageal cancer. The American Journal of Surgery 2004;188:254-60. [DOI: 10.1016/j.amjsurg.2004.06.004] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
87 Almhanna K, Weber J, Shridhar R, Hoffe S, Strosberg J, Meredith K. Determining the optimal number of lymph nodes harvested during esophagectomy. J Gastrointest Oncol 2016;7:387-94. [PMID: 27284471 DOI: 10.21037/jgo.2015.12.02] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
88 Yang J, Zhang W, Xiao Z, Wang Q, Zhou Z, Zhang H, Chen D, Feng Q, He J, Gao S, Sun K, Liu X, Fang D, Mu J, Wang D, Li Y. The Impact of Postoperative Conformal Radiotherapy after Radical Surgery on Survival and Recurrence in Pathologic T3N0M0 Esophageal Carcinoma: A Propensity Score-Matched Analysis. J Thorac Oncol. 2017;12:1143-1151. [PMID: 28411098 DOI: 10.1016/j.jtho.2017.03.024] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 3.6] [Reference Citation Analysis]
89 Ludeman L, Shepherd NA. Serosal involvement in gastrointestinal cancer: its assessment and significance. Histopathology. 2005;47:123-131. [PMID: 16045772 DOI: 10.1111/j.1365-2559.2005.02189.x] [Cited by in Crossref: 56] [Cited by in F6Publishing: 49] [Article Influence: 3.3] [Reference Citation Analysis]
90 Sudo N, Ichikawa H, Muneoka Y, Hanyu T, Kano Y, Ishikawa T, Hirose Y, Miura K, Shimada Y, Nagahashi M, Sakata J, Kobayashi T, Bamba T, Nakagawa S, Kosugi SI, Wakai T. Clinical Utility of ypTNM Stage Grouping in the 8th Edition of the American Joint Committee on Cancer TNM Staging System for Esophageal Squamous Cell Carcinoma. Ann Surg Oncol 2021;28:650-60. [PMID: 33025354 DOI: 10.1245/s10434-020-09181-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
91 Jennings NA, Griffin SM, Lamb PJ, Preston S, Richardson D, Karat D, Hayes N. Prospective study of bone scintigraphy as a staging investigation for oesophageal carcinoma. Br J Surg 2008;95:840-4. [PMID: 18551472 DOI: 10.1002/bjs.6175] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
92 Shi M, Wang Z, Song L, Wang D, Sun Z. Low expression of claudin-4: an indicator of recurrence in esophageal squamous cell carcinoma after Ivor Lewis esophagectomy? Med Oncol 2014;31:951. [PMID: 24737010 DOI: 10.1007/s12032-014-0951-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
93 Huang W, Wu L, Liu X, Long H, Rong T, Ma G. Preoperative serum C-reactive protein levels and postoperative survival in patients with esophageal squamous cell carcinoma: a propensity score matching analysis. J Cardiothorac Surg 2019;14:167. [PMID: 31533862 DOI: 10.1186/s13019-019-0981-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
94 Yu E, Dar R, Rodrigues GB, Stitt L, Videtic GM, Truong P, Tomiak A, Ash R, Brecevic E, Inculet R, Malthaner R, Vincent M, Craig I, Kocha W, Lefcoe M. Is extended volume external beam radiation therapy covering the anastomotic site beneficial in post-esophagectomy high risk patients? Radiotherapy and Oncology 2004;73:141-8. [DOI: 10.1016/j.radonc.2004.08.024] [Cited by in Crossref: 9] [Cited by in F6Publishing: 13] [Article Influence: 0.5] [Reference Citation Analysis]
95 Waraich N, Rashid F, Jan A, Semararo D, Deb R, Leeder P, Iftikhar S. Vascular invasion is not a risk factor in oesophageal cancer recurrence. International Journal of Surgery 2011;9:237-40. [DOI: 10.1016/j.ijsu.2010.12.002] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
96 Healy LA, Ryan AM, Moore J, Rowley S, Ravi N, Byrne PJ, Reynolds JV. Health-related quality of life assessment at presentation may predict complications and early relapse in patients with localized cancer of the esophagus: Quality of life is associated with outcomes after esophagectomy. Diseases of the Esophagus 2008;21:522-8. [DOI: 10.1111/j.1442-2050.2008.00814.x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 1.6] [Reference Citation Analysis]
97 Lamb P, Griffin SM. Carcinoma of the Oesophagus. Surgery (Oxford) 2003;21:1-4. [DOI: 10.1383/surg.21.1.1.14546] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
98 Ma G, Zhang X, Ma Q, Rong T, Long H, Lin P, Fu J, Zhang L. A novel multivariate scoring system for determining the prognosis of lymph node-negative esophageal squamous cell carcinoma following surgical therapy: an observational study. Eur J Surg Oncol 2015;41:541-7. [PMID: 25659876 DOI: 10.1016/j.ejso.2015.01.013] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
99 Veuillez V, Rougier P, Seitz JF. The multidisciplinary management of gastrointestinal cancer. Multimodal treatment of oesophageal cancer. Best Pract Res Clin Gastroenterol. 2007;21:947-963. [PMID: 18070697 DOI: 10.1016/j.bpg.2007.10.005] [Cited by in Crossref: 15] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
100 Liu S, Zhu H, Li W, Zhang B, Ma L, Guo Z, Huang Y, Song P, Yu J, Guo H. Potential impact of (18)FDG-PET/CT on surgical approach for operable squamous cell cancer of middle-to-lower esophagus. Onco Targets Ther 2016;9:855-62. [PMID: 26955283 DOI: 10.2147/OTT.S97896] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
101 Li J, Wen Y, Xiang Z, Du H, Geng L, Yang X, Zhang Y, Bai J, Dai T, Feng G, Liu L, Du X. Radical radiotherapy for metachronous oligometastasis after initial treatment of esophageal cancer. Radiother Oncol 2021;154:201-6. [PMID: 32980382 DOI: 10.1016/j.radonc.2020.09.042] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
102 Yasuda T, Yano M, Miyata H, Yamasaki M, Higuchi I, Takiguchi S, Fujiwara Y, Doki Y. Systemic control and evaluation of the response to neoadjuvant chemotherapy in resectable thoracic esophageal squamous cell carcinoma with 18F-fluorodeoxyglucose positron emission tomography-positive lymph nodes. Surg Today 2015;45:335-45. [DOI: 10.1007/s00595-014-0956-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
103 Xu Y, Chen Q, Yu X, Zhou X, Zheng X, Mao W. Factors influencing the risk of recurrence in patients with esophageal carcinoma treated with surgery: A single institution analysis consisting of 1002 cases. Oncol Lett. 2013;5:185-190. [PMID: 23255917 DOI: 10.3892/ol.2012.1007] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
104 Tait DM. Multi-modality treatment in oesophageal cancer: a curse for radiotherapy progress. Radiotherapy and Oncology 2004;73:115-7. [DOI: 10.1016/j.radonc.2004.08.010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
105 Miyata H, Yamasaki M, Makino T, Miyazaki Y, Takahashi T, Kurokawa Y, Nakajima K, Takiguchi S, Mori M, Doki Y. Therapeutic value of lymph node dissection for esophageal squamous cell carcinoma after neoadjuvant chemotherapy. J Surg Oncol 2015;112:60-5. [PMID: 26179950 DOI: 10.1002/jso.23965] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
106 Hiranyatheb P, Osugi H. Radical lymphadenectomy in esophageal cancer: from the past to the present. Dis Esophagus. 2013;Jun 24; Epub ahead of print. [PMID: 23796327 DOI: 10.1111/dote.12091] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
107 Hamai Y, Hihara J, Emi M, Furukawa T, Ibuki Y, Yamakita I, Kurokawa T, Okada M. Treatment Outcomes and Prognostic Factors After Recurrence of Esophageal Squamous Cell carcinoma. World J Surg 2018;42:2190-8. [DOI: 10.1007/s00268-017-4430-8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
108 Kobayashi R, Yamashita H, Okuma K, Shiraishi K, Ohtomo K, Nakagawa K. Salvage radiation therapy and chemoradiation therapy for postoperative locoregional recurrence of esophageal cancer. Dis Esophagus 2014;27:72-8. [PMID: 23551708 DOI: 10.1111/dote.12068] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
109 Jiang W, Wang Z, Jia Y. CEP55 overexpression predicts poor prognosis in patients with locally advanced esophageal squamous cell carcinoma. Oncol Lett 2017;13:236-42. [PMID: 28123547 DOI: 10.3892/ol.2016.5414] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
110 Anandavadivelan P, Wikman A, Johar A, Lagergren P. Profiles of patient and tumour characteristics in relation to health-related quality of life after oesophageal cancer surgery. PLoS One 2018;13:e0196187. [PMID: 29708994 DOI: 10.1371/journal.pone.0196187] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
111 Qiao XY, Wang W, Zhou ZG, Gao XS, Chang JY. Comparison of efficacy of regional and extensive clinical target volumes in postoperative radiotherapy for esophageal squamous cell carcinoma. Int J Radiat Oncol Biol Phys 2008;70:396-402. [PMID: 17855004 DOI: 10.1016/j.ijrobp.2007.06.031] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 0.7] [Reference Citation Analysis]
112 Benech N, O'Brien JM, Barret M, Jacques J, Rahmi G, Perrod G, Hervieu V, Jaouen A, Charissoux A, Guillaud O, Legros R, Walter T, Saurin JC, Rivory J, Prat F, Lépilliez V, Ponchon T, Pioche M. Endoscopic resection of Barrett's adenocarcinoma: Intramucosal and low-risk tumours are not associated with lymph node metastases. United European Gastroenterol J 2021;9:362-9. [PMID: 32903167 DOI: 10.1177/2050640620958903] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
113 Thomson IG, Smithers BM, Gotley DC, Martin I, Thomas JM, O'Rourke P, Barbour AP. Thoracoscopic-assisted esophagectomy for esophageal cancer: analysis of patterns and prognostic factors for recurrence. Ann Surg 2010;252:281-91. [PMID: 20647926 DOI: 10.1097/SLA.0b013e3181e909a2] [Cited by in Crossref: 33] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
114 McNamee P, Glendinning S, Shenfine J, Steen N, Griffin SM, Bond J. Chained time trade-off and standard gamble methods. Applications in oesophageal cancer. Eur J Health Econ 2004;5:81-6. [PMID: 15452769 DOI: 10.1007/s10198-003-0217-y] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
115 Schizas D, Vailas M, Sotiropoulou M, A Ziogas I, S Mylonas K, Katsaros I, Kapelouzou A, Liakakos T. Surgery for metachronous oligometastatic esophageal cancer: Is there enough evidence? Cir Esp 2021;99:490-9. [PMID: 33894971 DOI: 10.1016/j.ciresp.2021.03.003] [Reference Citation Analysis]
116 Schizas D, Vailas M, Sotiropoulou M, A Ziogas I, S Mylonas K, Katsaros I, Kapelouzou A, Liakakos T. Surgery for metachronous oligometastatic esophageal cancer: Is there enough evidence? Cir Esp (Engl Ed) 2021;99:490-9. [PMID: 34353590 DOI: 10.1016/j.cireng.2021.07.006] [Reference Citation Analysis]
117 Fujiwara Y, Fukuda S, Tsujie M, Kitani K, Yukawa M, Inoue M, Watanabe Y, Higashida M, Kubota H, Okada T, Tsuruta A, Ueno T. Clinical significance of preoperative chemoradiotherapy for advanced esophageal cancer, evaluated by propensity score matching and weighting of inverse probability of treatment. Mol Clin Oncol 2019;10:575-82. [PMID: 31086666 DOI: 10.3892/mco.2019.1843] [Reference Citation Analysis]
118 Deng W, Zhang W, Yang J, Ni W, Yu S, Li C, Chang X, Zhou Z, Chen D, Feng Q, Chen X, Lin Y, Zhu K, Zheng X, He J, Gao S, Xue Q, Mao Y, Cheng G, Sun K, Liu X, Fang D, Chen J, Xiao Z. Nomogram to Predict Overall Survival for Thoracic Esophageal Squamous Cell Carcinoma Patients After Radical Esophagectomy. Ann Surg Oncol 2019;26:2890-8. [DOI: 10.1245/s10434-019-07393-w] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
119 Hatogai K, Fujii S, Kojima T, Daiko H, Kadota T, Fujita T, Yoshino T, Doi T, Takiguchi Y, Ohtsu A. Prognostic significance of tumor regression grade for patients with esophageal squamous cell carcinoma after neoadjuvant chemotherapy followed by surgery. J Surg Oncol 2016;113:390-6. [PMID: 27100024 DOI: 10.1002/jso.24151] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]
120 Seesing MFJ, van der Veen A, Brenkman HJF, Stockmann HBAC, Nieuwenhuijzen GAP, Rosman C, van den Wildenberg FJH, van Berge Henegouwen MI, van Duijvendijk P, Wijnhoven BPL, Stoot JHMB, Lacle M, Ruurda JP, van Hillegersberg R; Gastroesophageal Metastasectomy Group. Resection of hepatic and pulmonary metastasis from metastatic esophageal and gastric cancer: a nationwide study. Dis Esophagus 2019;32:doz034. [PMID: 31220859 DOI: 10.1093/dote/doz034] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
121 Kemper M, Izbicki JR, Reeh M. Is There an Optimal Definition for a Positive Circumferential Resection Margin in Locally Advanced Esophageal Cancer? Ann Surg Oncol 2021;28:8020-1. [PMID: 34618248 DOI: 10.1245/s10434-021-10837-x] [Reference Citation Analysis]
122 Yamashita H, Jingu K, Niibe Y, Katsui K, Matsumoto T, Nishina T, Terahara A. Definitive salvage radiation therapy and chemoradiation therapy for lymph node oligo-recurrence of esophageal cancer: a Japanese multi-institutional study of 237 patients. Radiat Oncol 2017;12:38. [PMID: 28219406 DOI: 10.1186/s13014-017-0780-5] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
123 Boone J, Schipper ME, Moojen WA, Borel Rinkes IH, Cromheecke GJ, van Hillegersberg R. Robot-assisted thoracoscopic oesophagectomy for cancer. Br J Surg. 2009;96:878-886. [PMID: 19591168 DOI: 10.1002/bjs.6647] [Cited by in Crossref: 97] [Cited by in F6Publishing: 86] [Article Influence: 7.5] [Reference Citation Analysis]
124 Crosby TD, Brewster AE, Borley A, Perschky L, Kehagioglou P, Court J, Maughan TS. Definitive chemoradiation in patients with inoperable oesophageal carcinoma. Br J Cancer. 2004;90:70-75. [PMID: 14710209 DOI: 10.1038/sj.bjc.6601461] [Cited by in Crossref: 76] [Cited by in F6Publishing: 76] [Article Influence: 4.2] [Reference Citation Analysis]
125 Hsu PK, Wang BY, Chou TY, Huang CS, Wu YC, Hsu WH. The total number of resected lymph node is not a prognostic factor for recurrence in esophageal squamous cell carcinoma patients undergone transthoracic esophagectomy. J Surg Oncol 2011;103:416-20. [PMID: 21400526 DOI: 10.1002/jso.21850] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
126 Bao Y, Liu S, Zhou Q, Cai P, Anfossi S, Li Q, Hu Y, Liu M, Fu J, Rong T. Three-dimensional conformal radiotherapy with concurrent chemotherapy for postoperative recurrence of esophageal squamous cell carcinoma: clinical efficacy and failure pattern. Radiat Oncol. 2013;8:241. [PMID: 24139225 DOI: 10.1186/1748-717x-8-241] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
127 Berrisford RG, Wajed SA, Sanders D, Rucklidge MWM. Short-term outcomes following total minimally invasive oesophagectomy. British Journal of Surgery 2008;95:602-10. [DOI: 10.1002/bjs.6054] [Cited by in Crossref: 56] [Cited by in F6Publishing: 41] [Article Influence: 4.0] [Reference Citation Analysis]
128 Mine S, Watanabe M, Kumagai K, Okamura A, Yamashita K, Hayami M, Yuda M, Imamura Y, Ishizuka N. Oesophagectomy with or without supraclavicular lymphadenectomy after neoadjuvant treatment for squamous cell carcinoma of the oesophagus. British Journal of Surgery 2018;105:1793-8. [DOI: 10.1002/bjs.10960] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
129 Feng MX, Wang H, Zhang Y, Tan LJ, Xu ZL, Qun W. Minimally invasive esophagectomy for esophageal squamous cell carcinoma: a case-control study of thoracoscope versus mediastinoscope assistance. Surg Endosc 2012;26:1573-8. [PMID: 22179461 DOI: 10.1007/s00464-011-2073-7] [Cited by in Crossref: 17] [Cited by in F6Publishing: 22] [Article Influence: 1.5] [Reference Citation Analysis]
130 Deng W, Chen J, Xiao Z. ASO Author Reflections: Prognostic Stratification and the Value of Adjuvant Therapy in Thoracic Esophageal Squamous Cell Carcinoma Patients After Esophagectomy. Ann Surg Oncol 2019;26:802-3. [PMID: 31654164 DOI: 10.1245/s10434-019-07728-7] [Reference Citation Analysis]
131 Sun L, Su XH, Guan YS, Pan WM, Luo ZM, Wei JH, Zhao L, Wu H. Clinical usefulness of 18F-FDG PET/CT in the restaging of esophageal cancer after surgical resection and radiotherapy. World J Gastroenterol 2009; 15(15): 1836-1842 [PMID: 19370780 DOI: 10.3748/wjg.15.1836] [Cited by in CrossRef: 15] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
132 Lee DH, Kim HR, Kim DK, Park SI, Kim YH. Outcomes of cervical lymph node recurrence in patients with esophageal squamous cell carcinoma after esophagectomy with 2-field lymph node dissection. J Thorac Cardiovasc Surg. 2013;146:365-371. [PMID: 23422046 DOI: 10.1016/j.jtcvs.2013.01.043] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
133 Botha AJ, Odendaal W, Patel V, Watcyn-Jones T, Mahadeva U, Chang F, Deere H. Total adventitial resection of the cardia: 'optimal local resection' for tumours of the oesophagogastric junction. Ann R Coll Surg Engl 2011;93:608-14. [PMID: 22041237 DOI: 10.1308/003588411X13165261994111] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
134 Miyata H, Yamasaki M, Kurokawa Y, Takiguchi S, Nakajima K, Fujiwara Y, Mori M, Doki Y. Multimodal treatment for resectable esophageal cancer. Gen Thorac Cardiovasc Surg 2011;59:461-6. [PMID: 21751104 DOI: 10.1007/s11748-011-0780-6] [Cited by in Crossref: 13] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
135 Delaney G, Barton M, Jacob S. Estimation of an optimal radiotherapy utilization rate for gastrointestinal carcinoma: A review of the evidence. Cancer 2004;101:657-70. [DOI: 10.1002/cncr.20443] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 1.2] [Reference Citation Analysis]
136 Baba Y, Watanabe M, Kawanaka K, Iwagami S, Ishimoto T, Iwatsuki M, Yoshida N, Yamashita Y, Baba H. Radiofrequency ablation for pulmonary metastases from esophageal squamous cell carcinoma. Dis Esophagus 2014;27:36-41. [PMID: 23384275 DOI: 10.1111/dote.12034] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
137 Fan N, Yang H, Zheng J, Chen D, Wang W, Tan Z, Huang Y, Lin P. Comparison of short- and long-term outcomes between 3-field and modern 2-field lymph node dissections for thoracic oesophageal squamous cell carcinoma: a propensity score matching analysis. Interact Cardiovasc Thorac Surg 2019;29:434-41. [PMID: 31135037 DOI: 10.1093/icvts/ivz108] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
138 Smit JK, Pultrum BB, van Dullemen HM, Van Dam GM, Groen H, Plukker JT. Prognostic factors and patterns of recurrence in esophageal cancer assert arguments for extended two-field transthoracic esophagectomy. Am J Surg 2010;200:446-53. [PMID: 20409512 DOI: 10.1016/j.amjsurg.2009.12.006] [Cited by in Crossref: 35] [Cited by in F6Publishing: 32] [Article Influence: 2.9] [Reference Citation Analysis]
139 Shim YM, Kim HK, Kim K. Comparison of survival and recurrence pattern between two-field and three-field lymph node dissections for upper thoracic esophageal squamous cell carcinoma. J Thorac Oncol 2010;5:707-12. [PMID: 20421764 DOI: 10.1097/JTO.0b013e3181d3ccb2] [Cited by in Crossref: 42] [Cited by in F6Publishing: 23] [Article Influence: 3.5] [Reference Citation Analysis]
140 Yamamoto S, Kawahara K, Maekawa T, Shiraishi T, Shirakusa T. Minimally Invasive Esophagectomy for Stage I and II Esophageal Cancer. The Annals of Thoracic Surgery 2005;80:2070-5. [DOI: 10.1016/j.athoracsur.2005.06.004] [Cited by in Crossref: 45] [Cited by in F6Publishing: 40] [Article Influence: 2.6] [Reference Citation Analysis]
141 Voron T, Gronnier C, Pasquer A, Thereaux J, Gagniere J, Lebreton G, Meunier B, Collet D, Piessen G, Paye F; FREGAT working group - FRENCH. Adenocarcinoma of the oesophagogastric junction Siewert II: An oesophageal cancer better cured with total gastrectomy. Eur J Surg Oncol 2019;45:2473-81. [PMID: 31350076 DOI: 10.1016/j.ejso.2019.07.022] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]